Blood Loss, Surgical Clinical Trial
Official title:
Comparison of Methods and Coagulation Analysis Between ROTEM Sigma and Quantra System in Cardiac Surgery
NCT number | NCT04310124 |
Other study ID # | HEMCS-ZU |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 17, 2018 |
Est. completion date | December 5, 2019 |
Verified date | March 2020 |
Source | HemoSonics LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study compares the results of the Quantra System with the QPlus Cartridge to results obtained with the ROTEM sigma in patients undergoing cardia surgery utilizing cardiopulmonary bypass.
Status | Completed |
Enrollment | 38 |
Est. completion date | December 5, 2019 |
Est. primary completion date | July 16, 2019 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients scheduled for cardiac surgery needing a cardiopulmonary bypass - Age 18 years or older - Written consent of the participation after clarification about the study Exclusion Criteria: - No consent to participate - No German comprehension |
Country | Name | City | State |
---|---|---|---|
Switzerland | Klinik Im Park Zurich | Zurich |
Lead Sponsor | Collaborator |
---|---|
HemoSonics LLC |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of Quantra Clot Time results to ROTEM INTEM Clot Time results | Coagulation function assessed by Quantra and ROTEM sigma | Baseline | |
Primary | Comparison of Quantra Clot Time results to ROTEM INTEM Clot Time results | Coagulation function assessed by Quantra and ROTEM sigma | End of cardiopulmonary bypass | |
Primary | Comparison of Quantra Heparinase Clot Time results to ROTEM HEPTEM Clot Time results | Coagulation function assessed by Quantra and ROTEM sigma | Baseline | |
Primary | Comparison of Quantra Heparinase Clot Time results to ROTEM HEPTEM Clot Time results | Coagulation function assessed by Quantra and ROTEM sigma | End of cardiopulmonary bypass | |
Primary | Comparison of Quantra Clot Stiffness results to ROTEM EXTEM A10 results | Coagulation function assessed by Quantra and ROTEM sigma | Baseline | |
Primary | Comparison of Quantra Clot Stiffness results to ROTEM EXTEM A10 results | Coagulation function assessed by Quantra and ROTEM sigma | End of cardiopulmonary bypass | |
Primary | Comparison of Quantra Fibrinogen Contribution to Clot Stiffness results to ROTEM FIBTEM A10 results | Coagulation function assessed by Quantra and ROTEM sigma | Baseline | |
Primary | Comparison of Quantra Fibrinogen Contribution to Clot Stiffness results to ROTEM FIBTEM A10 results | Coagulation function assessed by Quantra and ROTEM sigma | End of cardiopulmonary bypass | |
Primary | Comparison of Quantra Platelet Contribution to Clot Stiffness results to ROTEM PLATEM (calculated) results | Coagulation function assessed by Quantra and ROTEM sigma | Baseline | |
Primary | Comparison of Quantra Platelet Contribution to Clot Stiffness results to ROTEM PLATEM (calculated) results | Coagulation function assessed by Quantra and ROTEM sigma | End of cardiopulmonary bypass | |
Primary | Comparison of Quantra time to results to ROTEM sigma time to results | Time from start of test to final results | Baseline | |
Primary | Comparison of Quantra time to results to ROTEM sigma time to results | Time from start of test to final results | End of cardiopulmonary bypass |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04114253 -
QStat in Liver Transplant
|
||
Recruiting |
NCT05077124 -
Safe and Timely Antithrombotic Removal (STAR) Registry
|
||
Active, not recruiting |
NCT03651154 -
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections
|
N/A | |
Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
Completed |
NCT02043132 -
Tranexamic Acid in Reverse Total Shoulder Arthroplasty
|
Phase 2/Phase 3 | |
Withdrawn |
NCT00861367 -
Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate
|
N/A | |
Terminated |
NCT03246919 -
Ideal Time of Oxytocin Infusion During Cesarean Section
|
Phase 4 | |
Completed |
NCT04443920 -
Tranexamic Acid for Total Knee Arthroscopy
|
Phase 4 | |
Withdrawn |
NCT04933253 -
Mediastinal Temperature and Post-operative Bleeding
|
N/A | |
Recruiting |
NCT02938962 -
Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)
|
Phase 4 | |
Recruiting |
NCT02130752 -
Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery
|
N/A | |
Recruiting |
NCT05164809 -
Effect of Electrosurgery on Blood Loss and Intraoperative Transfusions in Musculoskeletal Tumor Surgery
|
||
Not yet recruiting |
NCT04574128 -
Retransfusion or Not of Cardiotomy Blood
|
N/A | |
Completed |
NCT02911831 -
IV Tranexamic Acid Prior to Hysterectomy
|
Early Phase 1 | |
Completed |
NCT02740374 -
Evaluation of Thromboelastometry (ROTEM) During Spinal Surgery
|
N/A | |
Enrolling by invitation |
NCT05474027 -
Reducing Hypotensive Anesthesia Use With TXA During Orthognathic Surgery
|
Phase 4 | |
Completed |
NCT05391607 -
Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement
|
Phase 4 | |
Completed |
NCT03152461 -
Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge
|
||
Recruiting |
NCT02441751 -
Intraoperative Volume Management and QT Interval
|
||
Completed |
NCT01053169 -
Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)
|
N/A |